These mutations have been associated with decreased apoptosis [23] and have been shown to activate the PI3K/AKT/mTOR pathway, which is potentially involved with tumor progression [24] and has been associated with tumorigenesis of other cancer types [25]. This evidence concerns the gene MTOR and neoplasm.